Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders
Friday April 27, 2018 3:30 pm to 5:30 pm
Jill Ostrem MD
Deep brain stimulation therapy is widely used to treat medically refractory movement disorders, including essential tremor, Parkinson's disease, and dystonia. Understanding the DBS system, proper patient selection, accurate lead placement, and optimized postoperative management are essential for successful outcomes. Each issue will be discussed, with an emphasis on practical information for clinicians. This course has been divided into two sequential sessions. Those registering for the course are encouraged to participate in both sessions for a comprehensive overview of the topic. Part I focuses on basic DBS principles and programming issues in movement disorders. Part II focuses on more advanced DBS issues in movement disorders and also highlight DBS in non-movement disorders conditions. These programs will include case-based discussions highlighting patient candidacy and management of DBS.
This program complements C229: Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders, but covers independent topics.
Participants will be able to describe the rationale for the use of DBS and the patients for whom the treatment is most indicated. They will have a general understanding of the principles of DBS programming and strategies for troubleshooting common DBS-related management issues. They will also be aware of DBS applications in non-movement disorder conditions.
Medical Knowledge, Patient Care
Program Speakers - Tentative
3:30 PM - 3:35 PM
Jill L. Ostrem MD
3:35 PM - 4:25 PM
Advanced Management of PD, ET, Dystonia, and Troubleshooting
Joohi Jimenez Shahed MD
4:25 PM - 5:15 PM
Novel and Emerging Uses of DBS: OCD, Tourette Syndrome, Depression, Alzheimer's and Epilespy
Michael S. Okun MD, FAAN
5:15 PM - 5:30 PM
Joohi Jimenez Shahed MD, Michael S. Okun MD, FAAN, Jill L. Ostrem MD
Joohi Jimenez Shahed, MD
Dr. Jimenez Shahed has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with St. Jude Medical/Abbott, Medtronic, Teva and Bracket. Dr. Jimenez Shahed has received research support from Biotie, Medtronic and St. Jude Medical/Abbott.
Michael S. Okun, MD, FAAN
Dr. Okun has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with National Parkinson Foundation, Medscape and Mededicus. Dr. Okun has received personal compensation in an editorial capacity for New England Journal of Medicine Journal Watch and JAMA Neurology.
Jill L. Ostrem, MD
Dr. Ostrem has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Neurocrine and Adamas.
Ready to register for the 2018 AAN Annual Meeting?